Lataa...
Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome
BACKGROUND: Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify if there is differen...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879165/ https://ncbi.nlm.nih.gov/pubmed/31770398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0225737 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|